Analgesic Effects of Botulinum Toxin in Children with CP

被引:17
|
作者
Michelsen, Josephine Sandahl [1 ]
Normann, Gitte [1 ]
Wong, Christian [1 ]
机构
[1] Hvidovre Univ Hosp, Dept Orthoped, DK-2650 Hvidovre, Denmark
来源
TOXINS | 2018年 / 10卷 / 04期
关键词
pain; cerebral palsy; botulinum toxin A; QUALITY-OF-LIFE; RECURRENT MUSCULOSKELETAL PAIN; FUNCTION CLASSIFICATION-SYSTEM; CEREBRAL-PALSY; CLINICAL-PRACTICE; CONTROLLED-TRIAL; DOUBLE-BLIND; ADOLESCENTS; POPULATION; HEALTH;
D O I
10.3390/toxins10040162
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Experiencing pain is the greatest contributor to a reduced quality of life in children with cerebral palsy (CP). The presence of pain is quite common (60%) and increases with age. This leads to missed school days, less participation, and reduced ambulation. Despite these alarming consequences, strategies to relieve the pain are absent and poorly studied. Moreover, it is difficult to evaluate pain in this group of children, especially in cases of children with cognitive deficits, and tools for pain evaluation are often inadequate. Botulinum toxin has been shown to alleviate pain in a variety of disorders and could potentially have an analgesic effect in children with CP as well. Even though most of the studies presented here show promising results, many also have limitations in their methodology as it is unlikely to capture all dimensions of pain in this heterogeneous group using only one assessment tool. In this review, we present a new way of examining the analgesic effect of botulinum toxin in children with CP using a variety of pain scores.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Gait analysis in evaluation of botulinum toxin: a treatment in CP children
    Gallia, Manuela
    Crivellini, Marcello
    Motta, Francesco
    Critical Reviews in Biomedical Engineering, 1998, 26 (05):
  • [2] Analgesic effect of botulinum toxin in children with cerebral palsy: A systematic review
    Almina, Stramkauskaite
    Karile, Ylaite
    Audrone, Prasauskiene
    Indre, Bakaniene
    TOXICON, 2021, 199 : 60 - 67
  • [3] New analgesic: Focus on botulinum toxin
    Lackovic, Zdravko
    TOXICON, 2020, 179 : 1 - 7
  • [4] Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial
    Barwood, S
    Baillieu, C
    Boyd, R
    Brereton, K
    Low, J
    Nattrass, G
    Graham, HK
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (02): : 116 - 121
  • [5] Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain
    Ranoux, Daniele
    Attal, Nadine
    Morain, Francoise
    Bouhassira, D.
    ANNALS OF NEUROLOGY, 2008, 64 (03) : 274 - 283
  • [6] Use of botulinum toxin in pediatric spasticity (CP)
    Berweck, S
    Heinen, F
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R13 - R13
  • [7] Botulinum toxin A: Analgesic treatment for temporomandibular joint disorders
    Denglehem, C.
    Maes, J. -M.
    Raoul, G.
    Ferri, J.
    REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE, 2012, 113 (01) : 27 - 31
  • [8] Analgesic effect of botulinum toxin type A in Cervical Dystonia
    Couto, M.
    Ferreira, J. J.
    Coelho, M.
    Rosa, M. M.
    Sousa, A. T.
    Noronha, A.
    Sampaio, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 68 - 68
  • [9] A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A
    Voller, B
    Sycha, T
    Gustorff, B
    Schmetterer, L
    Lehr, S
    Eichler, HG
    Auff, E
    Schnider, P
    NEUROLOGY, 2003, 61 (07) : 940 - 944
  • [10] Botulinum toxin for achalasia in children
    Ip, KS
    Cameron, DJS
    Catto-Smith, AG
    Hardikar, W
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (10) : 1100 - 1104